Novartis | NVS - Текущие активы

Биржевая цена
154.05
Изменение за день
-1.03 -0.66%
Ежемесячно
-1.13%
Ежегодный
43.26%
Q2 прогноз
150.15




Текущие активы Изменить Дата
AbbVie USD 29.06B 523M 2025-12
Amgen USD 29.06B 1.17B 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Bausch Health Companies USD 6.16B 92M 2025-12
Biogen USD 8.97B 37.5M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Canopy Growth CAD 524.67M 78.85M 2025-12
Corcept Therapeutics USD 485.46M 55.67M 2025-12
Drreddys Laboratories INR 3.31B 164.26M 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Glaxosmithkline GBP 23.59B 390.44M 2025-12
J&J USD 55.62B 1.01B 2025-12
Merck USD 47.56B 10.49B 2025-09
Novartis USD 30.46B 2.26B 2025-12
Novartis USD 30.46B 2.26B 2025-12
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Phibro Animal Health USD 862.18M 26.39M 2025-12
Prestige Brands USD 433.43M 63.98M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.95B 3.09B 2025-12
Sanofi EUR 30.95B 8.99B 2025-12
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
Zoetis USD 6.77B 185M 2025-12